MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 297 filers reported holding MEDIVATION INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $56,792,000 | +47.2% | 941,850 | +12.3% | 0.06% | +37.0% |
| Q1 2016 | $38,570,000 | +32.9% | 838,861 | +39.8% | 0.05% | +39.4% |
| Q4 2015 | $29,014,000 | +0.6% | 600,210 | -11.6% | 0.03% | -5.7% |
| Q3 2015 | $28,843,000 | -38.1% | 678,675 | +66.2% | 0.04% | -22.2% |
| Q2 2015 | $46,631,000 | -4.7% | 408,335 | +7.8% | 0.04% | -8.2% |
| Q1 2015 | $48,907,000 | +29.5% | 378,920 | -0.0% | 0.05% | +44.1% |
| Q4 2014 | $37,756,000 | +18.2% | 379,046 | +17.4% | 0.03% | +30.8% |
| Q3 2014 | $31,931,000 | +68.8% | 322,959 | +31.6% | 0.03% | +73.3% |
| Q2 2014 | $18,916,000 | +22.6% | 245,404 | +2.4% | 0.02% | 0.0% |
| Q1 2014 | $15,426,000 | -40.7% | 239,645 | -41.2% | 0.02% | -37.5% |
| Q4 2013 | $26,025,000 | +67.4% | 407,781 | +57.2% | 0.02% | +60.0% |
| Q3 2013 | $15,551,000 | -3.9% | 259,445 | -21.1% | 0.02% | -6.2% |
| Q2 2013 | $16,178,000 | -12.0% | 328,824 | -16.3% | 0.02% | -15.8% |
| Q1 2013 | $18,380,000 | – | 393,085 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |